drugset / Trial / NCT02204917
CeVUS With Intravesical Administration of OPTISON TM (Trademark) in Children
NaSingle-groupOpen-labelDiagnostic
Summary
In this clinical trial the investigators aim to evaluate the diagnostic feasibility and safety of ceVUS with the intravesical use of OPTISON for vesicoureteral reflux detection and urethral imaging in children.
Timeline
- Start
- 2014-07
- Primary completion
- 2016-03
- Completion
- 2017-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Optison | Diagnostic / imaging agent | 0.1 % | — |
| Subject | Optison | Diagnostic / imaging agent | 0.3 ml | — |
| Subject | Optison | Diagnostic / imaging agent | 0.5 % | — |
| Subject | Optison | Diagnostic / imaging agent | 3 ml | — |